Markham Richard J

CIK 00013627435 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001362743

Recent Transactions

47 trades

Award
Vaxart, Inc.$VXRT
Stock Option (right to buy)
2019-06-12+12,700→ 12,700 total
Award
Vaxart, Inc.$VXRT
Stock Option (right to buy)
2019-06-12+9,000→ 9,000 total
Award
Vaxart, Inc.$VXRT
Common Stock
2018-02-13+30,793,670→ 30,793,670 total
Conversion
CoLucid Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2015-05-11−1,199,841→ 0 total
Conversion
CoLucid Pharmaceuticals, Inc.
Series C Convertible Preferred Stock
2015-05-11−320,295→ 0 total
Conversion
CoLucid Pharmaceuticals, Inc.
Series C Convertible Preferred Stock
2015-05-11−5,353→ 0 total
Conversion
CoLucid Pharmaceuticals, Inc.
Common Stock
2015-05-11+1,520,136→ 1,520,136 total
Conversion
CoLucid Pharmaceuticals, Inc.
Common Stock
2015-05-11+25,403→ 25,403 total
Conversion
CoLucid Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2015-05-11−20,050→ 0 total
Award
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2015-05-05+5,954→ 5,954 total
Award
NephroGenex, Inc.
Options to Purchase Common Stock
2015-04-30+6,870→ 6,870 total
Purchase
CoLucid Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2015-01-12+959,872→ 959,872 total
Purchase
CoLucid Pharmaceuticals, Inc.
Series C Convertible Preferred Stock
2015-01-12+5,353→ 5,353 total
Purchase
CoLucid Pharmaceuticals, Inc.
Series C Convertible Preferred Stock
2015-01-12+320,295→ 320,295 total
Purchase
CoLucid Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2015-01-12+16,041→ 16,041 total
Conversion
NephroGenex, Inc.
Common Stock
2014-02-14+890,140→ 3,038,505 total
Award
NephroGenex, Inc.
Common Stock
2014-02-14+412,592→ 3,451,097 total
Conversion
NephroGenex, Inc.
Common Stock
2014-02-14+2,148,365→ 2,148,365 total
Conversion
NephroGenex, Inc.
Series A Preferred Stock
2014-02-14+5,785,962→ 5,785,962 total
Conversion
NephroGenex, Inc.
Series A Preferred Stock
2014-02-14−13,964,398→ 0 total
Purchase
NephroGenex, Inc.
Common Stock
2014-02-14$12.00/sh+790,000→ 4,241,097 total
Conversion
NephroGenex, Inc.
8% Convertible Promissory Note
2014-02-14→ 0 total
Conversion
NephroGenex, Inc.
Series A Preferred Stock
2014-02-14−5,785,962→ 0 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2013-01-02+15,000→ 15,000 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2012-01-03+15,000→ 15,000 total
Award
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2011-05-25+15,000→ 15,000 total
Award
Anacor Pharmaceuticals, Inc.
Stock Option (right to buy)
2011-03-31+30,000→ 30,000 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2011-01-03+15,000→ 15,000 total
Conversion
Anacor Pharmaceuticals, Inc.
Common Stock
2010-11-30+107,004→ 1,558,104 total
Conversion
Anacor Pharmaceuticals, Inc.
Series E Preferred Stock
2010-11-30−107,004→ 0 total
Conversion
Anacor Pharmaceuticals, Inc.
Common Stock
2010-11-30+102,787→ 1,451,100 total
Conversion
Anacor Pharmaceuticals, Inc.
Series C Preferred Stock
2010-11-30−1,348,313→ 0 total
Conversion
Anacor Pharmaceuticals, Inc.
Common Stock
2010-11-30+1,348,313→ 1,348,313 total
Conversion
Anacor Pharmaceuticals, Inc.
Series D Preferred Stock
2010-11-30−102,787→ 0 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2010-03-05$4.77/sh−10,923→ 0 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2010-01-04+15,000→ 15,000 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2009-05-26$7.38/sh−10,000→ 10,923 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2009-05-22$7.50/sh−5,800→ 20,923 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2009-05-20$7.34/sh−6,000→ 26,723 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2009-05-15$7.04/sh−1,338→ 32,723 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2009-05-13$7.05/sh−7,028→ 34,061 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2009-05-08$6.93/sh−10,600→ 41,089 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2009-05-07$6.91/sh−12,900→ 51,689 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2009-05-06$6.79/sh−12,100→ 64,589 total
Sale
ACURA PHARMACEUTICALS, INC
Common Stock
2009-03-24$7.11/sh−35,000→ 76,689 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2009-01-02+15,000→ 15,000 total
Award
ACURA PHARMACEUTICALS, INC
Director Stock Options
2008-01-24+15,000→ 15,000 total

Companies

Recent Filings

Address

47 HULFISH STREET, SUITE 310

PRINCETON, NJ, 08542

View on SEC.gov